DNLI (denalitherapeutics.com) Kompaniya foydasi

Denali Therapeutics Inc. (DNLI) kompaniyasining rasmiy ramzlari

Denali Therapeutics (DNLI) operatsion natijalari miya degeneratsiyasiga qarshi kurashish uchun yetakchi neyrobiologlarni birlashtirgan biotexnologiya firmasi dinamikasini aks ettiradi. Biroq, ortib borayotgan R&D xarajatlari va sotuvlarning yo'qligi vaqtincha kengayishga to'sqinlik qilmoqda, shu bilan birga -0.51 joriy ko'rsatkichni shakllantirmoqda. Ishlab chiqish jarayoni sog'liqni saqlash gigantlari bilan strategik ittifoqlar orqali qon-miya to'sig'ini kesib o'tuvchi tizimlarni yaratishga asoslangan.

Kompaniyaning sof foydasi: denalitherapeutics.com (DNLI) 04.07.2022 - 31.10.2026 uchun

Denali Therapeutics Inc. (DNLI) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Denali Corp|DNLI - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Denali Corp|DNLI - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Bitta aksiya hisobiga sof aktivlar qiymati Denali Therapeutics|DNLI - Kompaniyaning balans qiymati|Kapitallashuvning balans qiymatiga nisbati denalitherapeutics.com|DNLI - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Denali Therapeutics|DNLI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Denali|DNLI - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Denali Corp|DNLI - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Denali Therapeutics|Oraliq likvidlik koeffitsiyenti denalitherapeutics.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
DNLI - Sof foyda
Fundamental baholash:DNLI - Denali Corp
Denali ishlab chiqargan mahsulot

Ushbu ko'rsatkich sof foydaning aksiyadorlik qiymatini kunlik asosda ob'yektiv ravishda o'lchaydi, bu esa uzoq muddatli kengayish potentsialini va tarixiy yuqori nuqtalarga yetganda haddan tashqari ko'p to'lov qilish xavfini baholash imkonini beradi. Denali Therapeutics (DNLI) uchun kompaniyaning hisobotdagi daromadlari uning qon-miya to'sig'ini kesib o'tuvchi noyob platformasining monetizatsiya samaradorligini aks ettiradi va neyrodegenerativ kasalliklarni davolash asosining moliyaviy barqarorligini belgilaydi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|VKTX: Kompaniya foydasi|Supernus Pharmaceuticals - Sof foyda|CPRX - Sof foyda|Harmony Biosciences Holdings, Inc. (HRMY) - Kompaniyaning sof foydasi|BHVN (Biohaven Ltd) - Kompaniyaning sof foydasi|AMLX (Amylyx) - Sof foyda|Trevi Corp (TRVI) - Sof moliyaviy natija|Sof daromad PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Yakuniy foyda|CeriBell - Sof daromad|Soliqlar to‘langandan keyingi foyda PRTA (Prothena Corp)|Alector Therapeutics - Sof foyda|Yakuniy foyda ANNX (Annexon Biosciences Inc.)|OMER: Sof foyda|Kompaniyaning sof daromadi neurogene.com (NGNE)|Kompaniyaning sof foydasi AC Immune SA|VYGR: Yakuniy foyda|Sof foyda NMRA|Sof foyda Scilex Holding Company, Inc. (SCLX)|Kompaniyaning sof foydasi Tevogen Bio Holdings TVGN|ACOG (Alpha Cognition Inc) - Soliqdan keyingi foyda|Cognition Therapeutics - Sof foyda|Kompaniyaning sof daromadi Inhibikase Therapeutics Inc|SAVA (Cassava) - Sof daromad|Assertio (ASRT) - Sof foyda|Sof daromad COYA|VTGN (VistaGen Therapeutics Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda OVID|Sof moliyaviy natija Acumen Pharmaceuticals Inc.|Sof foyda CRVO (CervoMed Inc)|ATHE - Sof daromad|CLNN - Kompaniyaning sof foydasi|Sof moliyaviy natija PepGen Inc. PEPG|JUNS: Sof foyda|Kompaniya foydasi RLMD|Kompaniyaning sof foydasi Annovis Bio Corp|Kompaniya foydasi GRCE (Grace Tx)|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Kompaniyaning sof foydasi KLTO (anewmeds.com)|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof moliyaviy natija Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Kompaniyaning sof foydasi|NRXS (NeurAxis Inc) - Kompaniya foydasi|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Sof daromad NEUP|Sof foyda Minerva Neurosciences Inc|Kompaniyaning sof foydasi Athira (ATHA)|ADXN (Addex) - Yakuniy foyda|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|Protagenic - Sof foyda|KTTA (Pasithea Therapeutics) - Kompaniya foydasi|CRGT: Sof foyda|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Kompaniyaning sof foydasi Brainstorm Cell|Kompaniya foydasi CARA (caratherapeutics.com)|Sof foyda CHRO|Sof foyda eliemtx.com (ELYM)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Longboard - Kompaniyaning sof foydasi|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NRBO (NeuroBo Pharmaceuticals, Inc.) - Sof daromad|Sage Therapeutics Inc. - Yakuniy foyda|Sof daromad SNPX|TRVN (Trevena Inc) - Soliqlar to‘langandan keyingi foyda|Sof foyda VIGL|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)